Compounds useful for treating cancer

Details for Australian Patent Application No. 2010258294 (hide)

Owner Institut Curie Universite Montpellier 2 Societe Splicos Centre National de la Recherche Scientifique

Inventors Roux, Pierre; Mahuteau, Florence; Najman, Romain; Tazi, Jamal; Gadea, Gilles

Agent A J Park

Pub. Number AU-A-2010258294

PCT Pub. Number WO2010/143168

Priority 61/186,552 12.06.09 US; 09305540.8 12.06.09 EP; 09162630.9 12.06.09 EP; 61/186,544 12.06.09 US

Filing date 14 June 2010

Wipo publication date 16 December 2010

International Classifications

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/444 (2006.01)

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/143168 Priority application(s): WO2010/143168

8 March 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Roux, Pierre; Mahuteau, Florence; Najman, Romain; Tazi, Jamal; Gadea, Gilles; Scherrer, Didier; Brock, Carsten and Cahuzac, Nathalie

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258295-Compounds useful for treating AIDS

2010258280-Production of plants with reduced lignin content